Nirsevimab and a Community Recall-Based Immunization Strategy for Child Bronchiolitis Prevention - Quiz - MDSpire

Nirsevimab and a Community Recall-Based Immunization Strategy for Child Bronchiolitis Prevention

  • By

  • Riccardo Boracchini

  • Benedetta Canova

  • Mirko Cesarini

  • Irene De Marchi

  • Giulia Brigadoi

  • Elisa Barbieri

  • Daniele Donà

  • Carlo Giaquinto

  • Eugenio Baraldi

  • Anna Cantarutti

  • May 19, 2026

  • 0 min

Share

Original Source(s)

Nirsevimab and a Community Recall-Based Immunization Strategy for Child Bronchiolitis Prevention

  • by Riccardo Boracchini, Benedetta Canova, Mirko Cesarini, Irene De Marchi, Giulia Brigadoi, Elisa Barbieri, Daniele Donà, Carlo Giaquinto, Eugenio Baraldi, Anna Cantarutti

  • May 19, 2026

Related Content

Revised U.S. Guidelines on Hepatitis B Vaccination Could Lead to Increased Infections and Healthcare Costs, Research Indicates

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Inside the rise of the ‘Make Europe Healthy Again’ movement